From the Department of Radiology (S.G., G.K., M.W., D.P., M.C.D.), Division of Neuro- and Musculoskeletal Radiology.
Department of Pediatrics and Adolescent Medicine (S.G., R.S.), Division of Pediatric Neurology.
AJNR Am J Neuroradiol. 2021 Apr;42(4):782-786. doi: 10.3174/ajnr.A7064. Epub 2021 Mar 11.
Although "corpus callosum agenesis" is an umbrella term for multiple entities, prenatal counseling is based reductively on the presence (associated) or absence (isolated) of additional abnormalities. Our aim was to test the applicability of a fetal MR neuroimaging score in a cohort of fetuses with prenatally diagnosed isolated corpus callosum agenesis and associated corpus callosum agenesis and correlate it with neurodevelopmental outcomes.
We performed a single-center retrospective analysis of a cohort of cases of consecutive corpus callosum agenesis collected between January 2011 and July 2019. Cases were scored by 2 raters, and interater agreement was calculated. Outcome was assessed by standardized testing (Bayley Scales of Infant and Toddler Development, Kaufman Assessment Battery for Children) or a structured telephone interview and correlated with scores using 2-way ANOVA.
We included 137 cases (74 cases of isolated corpus callosum agenesis), imaged at a mean of 27 gestational weeks. Interrater agreement was excellent (0.98). Scores were higher in associated corpus callosum agenesis (< .0001) without a significant score difference between complete and partial corpus callosum agenesis ( = .38). Outcome was assessed in 42 children with isolated corpus callosum agenesis and 9 with associated corpus callosum agenesis (mean age, 3.1 years). MR imaging scores correctly predicted developmental outcome in 90.7% of patients with isolated corpus callosum agenesis, improving neurodevelopmental risk stratification in corpus callosum agenesis.
The scoring system is very reproducible and can differentiate isolated corpus callosum agenesis and associated isolated corpus callosum agenesis (significantly higher scores) but not between partial and complete corpus callosum agenesis. Scores correlated with outcome in isolated corpus callosum agenesis, but there were too few associated postnatal cases of isolated corpus callosum agenesis to draw conclusions in this group.
虽然“胼胝体发育不全”是多种实体的统称,但产前咨询是基于额外异常的存在(相关)或不存在(孤立)进行简化的。我们的目的是在一组产前诊断为孤立性胼胝体发育不全和相关性胼胝体发育不全的胎儿中测试胎儿磁共振神经成像评分的适用性,并将其与神经发育结果相关联。
我们对 2011 年 1 月至 2019 年 7 月期间连续收集的胼胝体发育不全病例进行了单中心回顾性分析。病例由 2 名评分者进行评分,并计算了评分者间的一致性。通过标准化测试(贝利婴幼儿发育量表、考夫曼儿童评估量表)或结构化电话访谈评估结果,并使用双因素方差分析与评分相关联。
我们纳入了 137 例病例(74 例孤立性胼胝体发育不全),平均在 27 孕周进行成像。评分者间的一致性极好(0.98)。相关性胼胝体发育不全的评分较高(<0.0001),但完全性和部分性胼胝体发育不全之间的评分差异无统计学意义(=0.38)。孤立性胼胝体发育不全的 42 名儿童和相关性胼胝体发育不全的 9 名儿童进行了结果评估(平均年龄为 3.1 岁)。磁共振成像评分在 90.7%的孤立性胼胝体发育不全患者中正确预测了发育结果,改善了胼胝体发育不全的神经发育风险分层。
评分系统具有非常好的可重复性,可以区分孤立性胼胝体发育不全和相关性孤立性胼胝体发育不全(评分显著较高),但不能区分部分性和完全性胼胝体发育不全。评分与孤立性胼胝体发育不全的结果相关,但相关性孤立性胼胝体发育不全的产后病例太少,无法在该组中得出结论。